Biocon introduces oncologic biosimilar KRABEVA in India
The biosimilar product will be used for the treatment of patients with metastatic colorectal cancer and other types of lung, kidney, cervical, ovarian and brain cancers in India.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cervical Cancer | Colorectal Cancer | India Health | Neurology | Ovarian Cancer | Ovaries | Pharmaceuticals | Urology & Nephrology